April 10th 2024
From our April cover feature: Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Immunity Induction Therapy with Antibodies, Wound-Healing Therapies Show Potential
January 14th 2021Acne research delineating molecular and cellular pathogenic pathways gives insight into new therapeutic targets. According to a recent review, biologics and other therapies that modulate scar formation and wound healing will have value for treating severe acne.
Next-Generation Therapies and Approaches Will Advance Acne Treatment
January 13th 2021Topicals and oral antibiotics, as well as research on the skin microbiome, are paving the way for the future of acne treatment, according to a recent presentation at the 2020 ODAC Pre-Conference Inflammatory Diseases Symposium.
Adolescent acne therapies benefit younger children
December 2nd 2020A recent paper suggests younger children with acne vulgaris should be treated the same as adolescents. This includes utilizing combination therapies that may consist of topic retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics.
Narrow-spectrum antibiotics viable treatment option for acne
November 12th 2020Perceptions of antibiotics and potential antibiotic resistance have caused some physicians to be wary of the drug class when prescribing an acne treatment regimen. However, narrow-spectrum antibiotics have shown a low propensity for development of antimicrobial resistance while also effectively treating acne.
Mask fabrics and skin irritation
October 29th 2020With the rise in face mask usage, multiple types of masks have entered the market made of a variety of materials. Some, however, can lead to more skin irritation than others. Allison Truong, M.D., FAAD, provides some suggestions for the best type of mask to use and how to reduce skin irritation.
Specific dietary supplements linked to acne
October 29th 2020According to a recent review, supplements such as B6/B12, high-dose vitamins and whey protein have been linked to acne development. Study authors suggest physicians ask acne patients about their supplement use and educate them on potential side effects.
3D imaging technique measures severity of atrophic acne scars
October 11th 2020There is a dire need to improve the clinical tools dermatologists use to assess the severity of acne scars. This 3D imaging technique may help, according to a recent study presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.
Case series draws attention to phenotype of acne scarring
September 10th 2020A retrospective review of patients seen in an academic dermatology clinic over a one-year period identified 20 individuals with nasal papules in association with acne, which are thought to represent scarring sequelae. The condition is underrecognized, researchers say and requires further research to better understand.
Alembic Pharmaceuticals launches adapalene gel for acne vulgaris
September 1st 2020Alembic Pharmaceuticals announces the launch of their bioequivalent and therapeutically equivalent product to Differin Gel 0.3% (Galderma), Adapalene Gel USP 0.3%, a topical retinoid for the treatment of acne vulgaris in patients 12 years and older.
Will telemedicine impact the future of acne care?
August 14th 2020Will the current practice of using telemedicine for acne care have an impact on the future of dermatology? We spoke with Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, on the topic.